Press Release | Mon Apr 8, 2013 10:37am EDT

Merck to Present New Data on VICTRELIS® (boceprevir) and Investigational Compounds MK-5172 and Vaniprevir for Chronic Hepatitis C Virus at The International Liver CongressTM / 2013 EASL Annual Meeting

* Reuters is not responsible for the content in this press release.